Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,079 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

NCT01177397

Conditions
Adenocarcinoma, Astrocytoma, Blood Protein Disorders, +47 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Neuro-Oncology Program Los Angeles, California, United States
  • University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 16 locations
View Trial Details
Completed

Real-world Use of Carfilzomib Among Multiple Myeloma Patients in Europe

NCT03091127

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Krankenhaus Sankt Josef Braunau Braunau am Inn, Austria
  • Medizinische Universitaet Innsbruck Innsbruck, Austria
  • Landeskrankenhaus Hochsteiermark Leoben, Austria
  • Ordensklinikum Linz Elisabethinen Linz, Austria
View all 114 locations
View Trial Details
Completed

A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia

NCT03187262

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details

Related conditions